July 1, 2023

A Real-Time Science Report This is a reprint of a previous report. Dr. Bhatt will be back next month with a fresh update.  This article focuses...

June 1, 2023

A Real-Time Science Report I came across an interesting article about possible causes for Parkinson’s that the Parkinson’s community may like to know. Dr. Ray...

May 1, 2023

PARKINSON’S RESEARCHERS DISCOVER DISEASE BIOMARKER Parkinson’s disease is a neurodegenerative disease characterized pathologically by the formation of Lewy bodies comprised mainly of alpha-synuclein. Currently, definitive...

April 1, 2023

Parkinson’s disease is the most common neurodegenerative movement disorder characterized by bradykinesia, rigidity, postural instability, and tremor at rest. Dopamine replacement therapy is the...

March 1, 2023

A Real-Time Science Report Ram S. Bhatt, PhD., Chief Science Officer RISKS OF STEM CELL TRANSPLANT THERAPY FOR PARKINSON'S DISEASE On February 9, 2023, Magenta Therapeutics reported...

February 1, 2023

A Real-Time Science Report Ram S. Bhatt, PhD., Chief Science Officer STEM CELL THERAPY FOR PARKINSON'S DISEASE There has been a lot of talk recently on social...

January 1, 2023

A New Potential Therapeutic Target for Parkinson’s Disease Neurodegenerative Parkinson’s disease is characterized by a progressive loss of dopaminergic neurons from the nigrostriatal pathway, formation...

December 1, 2022

A Real-Time Science Report Ram S. Bhatt, PhD., Chief Science Officer EFFORTS TOWARDS A PARKINSON’S CURE The cure of any disease, including Parkinson’s, depends upon two key...

November 1, 2022

A Real-Time Science Report Ram S. Bhatt, PhD., Chief Science Officer Fibroblast Growth Factor 1 (FGF-1) - Scientists at Zhittya Genesis Medicine are looking at fibroblast...

July 28, 2022

A Real-Time Science Report Ram S. Bhatt, PhD., Chief Science Officer Last month, we discussed whether stem-cell therapy can produce dopamine producing neurons in the brain...

June 30, 2022

A Real-Time Science Report Ram S. Bhatt, PhD., Chief Science Officer The Role of LRRK2 in Parkinson’s disease – Mutations in the leucine-rich repeat kinase 2...